Distinct ALK-rearranged and VCL-negative papillary renal cell carcinoma variant in two adults without sickle cell trait

Modern Pathology

Volumn 26, Issue 4, 2013, Pages 604-605

  Hodge, Jennelle C ^a   Pearce, Kathryn E ^a   Sukov, William R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALK GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LETTER; MOLECULAR PATHOLOGY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SICKLE CELL TRAIT; TFE3 GENE; VCL GENE;

CARCINOMA, RENAL CELL; FEMALE; GENE FUSION; HUMANS; KIDNEY NEOPLASMS; MALE; RECEPTOR PROTEIN-TYROSINE KINASES; VINCULIN;

EID: 84876465660     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.144     Document Type: Letter

References (3)

1. Sukov W, Hodge J, Lohse C, et al. ALK alterations in adult renal cell carcinoma: Frequency, clinicopatholo-gic features and outcome in a large series of consecutively treated patients. Mod Pathol 2013 (in press).
2. Debelenko LV, Raimondi SC, Daw N, et al. Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol 2011;24:430-442.
3. Marino-Enriquez A, Ou WB, Weldon CB, et al. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chrom Cancer 2011;50: 146-153.